Topics

Essure Update: Almost All Unsold Units Back To Bayer; Postmarket Study Enrollment Complete

12:17 EST 15 Jan 2020 | SCRIP

The US FDA says Bayer has successfully recovered unsold Essure units and completed enrollment in a Sec. 522 postmarket study...

      

Related Stories

 

Original Article: Essure Update: Almost All Unsold Units Back To Bayer; Postmarket Study Enrollment Complete

NEXT ARTICLE

More From BioPortfolio on "Essure Update: Almost All Unsold Units Back To Bayer; Postmarket Study Enrollment Complete"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...